← Back to Search

Intranasal fentanyl for Abscess

Phase 3

Waitlist Available

Led By Benjamin Friedman, MD

Research Sponsored by Montefiore Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 120 minutes

Awards & highlights

Study Summary

This trial will compare the effectiveness of the drug fentanyl to a placebo at reducing pain during and after a medical procedure.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 120 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~120 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 120 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

NRS Pain Score After Blunt Dissection

NRS Pain Score After Irrigation

NRS Pain Score After Lidocaine Injection

+4 more

Secondary outcome measures

Health Care Providers Reported Perception of Study Medication Compared to Usual Care

Patient Satisfaction With Analgesia

Other outcome measures

Adverse events

Side effects

Trial Design

2Treatment groups

Experimental Treatment

Group I: PlaceboExperimental Treatment1 Intervention

0.04ml/kg of sterile water, administered via intranasal route by atomizer syringe

Group II: Intranasal fentanylExperimental Treatment1 Intervention

2 mcg/kg INF, administered via intranasal route by atomizer syringe

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Placebo

1995

Completed Phase 3

~2670

Intranasal fentanyl

2019

Completed Phase 4

~220

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Montefiore Medical CenterLead Sponsor

442 Previous Clinical Trials

582,477 Total Patients Enrolled

Benjamin Friedman, MDPrincipal InvestigatorMontefiore Medical Center

6 Previous Clinical Trials

1,793 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Why is Intranasal fentanyl commonly used?

"Intranasal fentanyl can be used for various anesthetic purposes, such as high risk surgery, preanesthetic medication, and anesthetic premedication therapy."

Answered by AI

Are there any openings for new participants in this trial?

"This particular study is no longer looking for new participants, as evidenced by the fact that the listing was last updated over 3 months ago. If you're interested in other abscess trials, there are 20 clinical studies currently recruiting patients. For those interested in other Intranasal fentanyl trials, there are 48 enrolling patients at the moment."

Answered by AI

Does this clinical research include elderly individuals as test subjects?

"This trial has an age limit of 64 years old, with a minimum age of 18 years old."

Answered by AI

What are the risks associated with Intranasal fentanyl use?

"There is some clinical evidence to support the efficacy of intranasal fentanyl, as well as data from multiple rounds of safety trials. Therefore, it receives a score of 3."

Answered by AI

Recent research and studies

Clinical Infectious DiseasesJournal

Emergency Department Visit Rates for Abscess Versus Other Skin Infections During the Emergence of Community-associated Methicillin-resistant Staphylococcus Aureus, 1997–2007

Qualls, Munirih L., Megan M. Mooney, Carlos A. Camargo Jr, Tanya Zucconi, David C. Hooper, and Daniel J. Pallin. 2012. “Emergency Department Visit Rates for Abscess Versus Other Skin Infections During the Emergence of Community-associated Methicillin-resistant Staphylococcus Aureus, 1997–2007”. Clinical Infectious Diseases. Oxford University Press (OUP). doi:10.1093/cid/cis342.

Western Journal of Emergency MedicineJournal

The Treatment of Cutaneous Abscesses: Comparison of Emergency Medicine Providers' Practice Patterns

Schmitz, Gillian, Tress Goodwin, Adam Singer, Chad Kessler, David Bruner, Hollynn Larrabee, Larissa May, Samuel Luber, Justin Williams, and Rahul Bhat. 2013. “The Treatment of Cutaneous Abscesses: Comparison of Emergency Medicine Providers' Practice Patterns”. Western Journal of Emergency Medicine. Western Journal of Emergency Medicine. doi:10.5811/westjem.2011.9.6856.

Annals of Emergency MedicineJournal

The Safety of Fentanyl Use in the Emergency Department

Chudnofsky, Carl R, Seth W Wright, Steven C Dronen, Stepehen W Borron, and Margaret B Wright. 1989. “The Safety of Fentanyl Use in the Emergency Department”. Annals of Emergency Medicine. Elsevier BV. doi:10.1016/s0196-0644(89)80517-7.

Emergency Medicine AustralasiaJournal